Erik T. Engelson
Richard Narido previously served as our Vice President of Finance, a role he has held since March 2021. As Chief Financial Officer, Mr. Narido will serve as our principal financial officer and principal accounting officer. From July 2018 to March 2021, Mr. Narido served in various roles at Assembly Biosciences, Inc., including most recently the Executive Director, Finance, and Treasury. From June 2014 to June 2018, Mr. Narido served in various roles at Bio-Rad Laboratories, including Americas Head of Finance, Global Commercial Operations. Prior to that, Mr. Narido held various finance roles, including Global Head Finance Reporting and Accounting for Novartis Vaccines and Diagnostics Division and several positions including business unit Controller for McKesson Corporation. Mr. Narido started his career with PricewaterhouseCoopers’s Financial Audit and Assurance practice. Mr. Narido holds a Bachelor of Science degree from University of San Francisco and a Master of Science degree from Pepperdine Graziadio Business School.